Global Psoriasis Treatment Market - Analysis By Type, By Treatment Method, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

Global Psoriasis Treatment Market - Analysis By Type, By Treatment Method, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

Executive Summary

Global Psoriasis Treatment Market was valued at USD 16.7 billion in the year 2019. Rising prevalence of psoriasis affected people, rise in research and investments in developing biological treatment, rise in awareness of psoriasis coupled with the rising demand for healthcare products are the major factors impelling the market growth. Major growth in the forecast period is likely to be demonstrated from the various drugs that are in the clinical stages and would be available commercially in the next 3-5 years. This includes among others, the most promising ARQ-154 Foam for scalp psoriasis, from the US biotechnology company, Arcutis, which has the potential to become a billion-dollar opportunity for the treatment of psoriasis.

Genetic disposition, rising geriatric population and increasing government initiatives creating psoriasis awareness have been anticipated to infuse growth in the market for Psoriasis during the forecasting period of 2020-2025. Factors such as rising geriatric population, practice of unhealthy lifestyle such as heavy consumption of alcohol, smoking tobacco, enaction of immunity framework, stress and sunburn are crucial factors are supposed to trigger Psoriasis and Psoriasis arthritis that is consequently accelerating the demand for Psoriasis treatment and medication. The growth of the market is hampered in 2020 due to the occurrence of coronavirus pandemic in which all worldwide business activities are put at hold for the first few months of the year. IPC recommended physicians to discontinue or postpone use of immunosuppressant medications for the psoriasis patients, which is negatively affecting the Psoriasis drugs market growth. However, as per National Psoriasis Foundation the Medicare extended its inclusion of telehealth administrations in amid COVID-19 pandemic due to which the treatment has been resumed and the drug market has been supported in few first few months of 2020 that are anticipated to recover and accelerate the demand for the treatment in the coming years.

Under the Type Segment, Plaque Psoriasis is the most common type of psoriasis and dominates the overall psoriasis market. The developing number of advanced medicines for the treatment of plaque psoriasis by the key players is augmenting the demand for enhanced medication.

The continual research and development in a number of biologics and biosimilars by the drug developing companies are expected to propel market demand of biologics treatment method for psoriasis. Among the regions, North America is followed by and Europe and Asia Pacific. Asia Pacific region is the most attractive region for the growth of Psoriasis treatment owing large targeted population base coupled with increasing healthcare spending, prevalence of psoriasis or psoriatic arthritis patients, rise in government contribution and awareness programs.

Scope of the Report

  • The report analyses Psoriasis market By Value
  • The report analyses Psoriasis Market By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis)
  • The report assesses the Psoriasis market By Treatment Method – (Biologics, Systemic Treatment, Topical Treatment, Others).
  • The Global Psoriasis Market has been analysed By Region (North America, Europe, Asia Pacific) and By Country (US, Canada, Norway, UK, Spain, Germany, China, India, South Korea, Japan).
  • The key insights of the report have been presented through the attractiveness of the market has been presented By Type, By Treatment Method and By Region. Additionally, the major opportunities, trends, drivers, challenges and pipeline products of the industry has been analysed in the report.
  • The companies analysed in the report include UCB, Sun Pharmaceutical Industries LTD, Boehringer Ingelheim, Almirall, Bausch Health, Abbvie Inc, Eli Lilly and Company, Pfizer Inc., Amgen Inc., Johnson & Johnson.
  • The report presents the analysis of Psoriasis market for the historical period of 2015-2019 and the forecast period of 2020-2025.


  • Key Target Audience
    • AD and Psoriasis Drug Developers
    • Pharmaceutical and Biotechnology Companies
    • Consulting and Advisory Firms
    • Government and Policy Makers
    • Investment Banks and Equity Firms
    • Regulatory Authorities


1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Global Psoriasis Treatment Market: Product Outlook
Table A: Treatment options for Psoriasis
4. Global Psoriasis Treatment Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025
Table 1: Global Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 2: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Table 3: Obese Population, By Country, 2017 (In Millions)
Table 4: Global Aged Population (Above 65), 2013-2017 (% of total)
Table 5: Global Aged Population(Above 65), By Country, 2017 (% of total)
Table 6: Global Health Expenditure, (% of GDP), 2014-2017
Table 7: Global Population Ages 65 and Above (% of total), 2015-2019
Table 8: Global Prevalence of Psoriasis, 2014-2017 (In Millions)
Table 9: Global Research and Development Expenditure, 2015-2018 (In % of GDP)
5. Global Psoriasis Treatment Market Segmentation By Type (By Value)
5.1 Competitive Scenario of Global Psoriasis Market – By Type (2019 & 2025)
Table 10: Global Psoriasis Market- By Type (2019 & 2025)
5.2 Plaque Psoriasis– Market Size and Forecast (2020-2025)
Table 11: Global Psoriasis Market- By Plaque Psoriasis, By Value (USD Million), 2015-2025
5.3 Inverse Psoriasis– Market Size and Forecast (2020-2025)
Table 12: Global Psoriasis Market- By Inverse Psoriasis, By Value (USD Million), 2015-2025
5.4 Guttate Psoriasis- Market Size and Forecast (2020-2025)
Table 13: Global Psoriasis Market- By Guttate Psoriasis, By Value (USD Million), 2015-2025
5.5 Pustular Psoriasis- Market Size and Forecast (2020-2025)
Table 14: Global Psoriasis Market- By Pustular Psoriasis, By Value (USD Million), 2015-2025
5.6 Erythrodermic Psoriasis- Market Size and Forecast (2020-2025)
Table 15: Global Psoriasis Market- By Erythrodermic Psoriasis, By Value (USD Million), 2015-2025
6. Global Psoriasis Market Segmentation By Treatment Method (By Value)
6.1 Competitive Scenario of Global Psoriasis – By Treatment Method (2019 & 2025)
Table 16: Global Psoriasis Market- By Treatment Method (2019 & 2025)
6.2 Biologics – Market Size and Forecast (2020-2025)
Table 17: Global Psoriasis Market- By Biologics, By Value (USD Million), 2015-2025
6.3 Systemic Treatment– Market Size and Forecast (2020-2025)
Table 18: Global Psoriasis Market- By Systemic Treatment, By Value (USD Million), 2015-2025
6.4 Topical Treatment– Market Size and Forecast (2020-2025)
Table 19: Global Psoriasis Market- By Topical Treatment, By Value (USD Million), 2015-2025
6.5 Others – Market Size and Forecast (2020-2025)
Table 20: Global Psoriasis Market- By Others, By Value (USD Million), 2015-2025
7. Global Psoriasis Market: Regional Analysis
7.1 Competitive Scenario of Global Psoriasis Market : By Region (2019 & 2025)
Table 21: Global Psoriasis Market- By Region (2019 & 2025)
8. North America Psoriasis Treatment Market: Segmentation By Type, By Treatment Method (2020-2025)
8.1 North America Psoriasis Market: Size and Forecast (2020-2025)
Table 22: North America Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 23: North America, Health Expenditure, (% of GDP), 2014-2017
Table 24: North America Population Ages 65 and Above (% of total), 2015-2019
Table 25: North America Prevalence of Psoriasis, 2014-2017 (In Millions)
Table 26: North America, Research and Development Expenditure, 2015-2018 (In % of GDP)
8.2 North America Prominent Companies in Psoriasis Market
Table B: Prominent Psoriasis companies operated in North America Market
8.3 Market Segmentation By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis- & Erythrodermic Psoriasis)
Table 27: North America Psoriasis Market- By Type, By Value (USD Million), 2015-2025
8.4 Market Segmentation By Treatment Method (Biologics, Systemic Treatment, Topical Treatment & Others)
Table 28: North America Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
8.5 North America Psoriasis Treatment Market: Country Analysis
8.6 Market Opportunity Chart of North America Psoriasis Market
Table 29: Market Opportunity Chart of North America Psoriasis Market - By Country, By Value (Year-2025) - By Country, By Value (Year-2025)
8.7 Competitive Scenario of North America Psoriasis Market: By Country (2019 & 2025)
Table 30: North America Psoriasis Market- By Country (2019 & 2025)
8.8 United States Psoriasis Market: Size and Forecast (2020-2025)
Table 31: United States Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 32: United States, Health Expenditure, (% of GDP), 2014-2017
Table 33: United States Population Ages 65 and Above (% of total), 2015-2019
Table 34: United States Prevalence of Psoriasis, 2014-2017 (In Millions)
Table 35: United States, Research and Development Expenditure, 2015-2018 (In % of GDP)
8.9 United States Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 36: United States Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 37: United States Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
8.10 Canada Psoriasis Market: Size and Forecast (2020-2025)
Table 38: Canada Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 39: Canada, Health Expenditure, (% of GDP), 2014-2017
Table 40: Canada Population Ages 65 and Above (% of total), 2015-2019
Table 41: Canada Prevalence of Psoriasis, 2014-2017 (In Millions)
Table 42: Canada, Research and Development Expenditure, 2015-2018 (In % of GDP)
8.11 Canada Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 43: Canada Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 44: Canada Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
9. Europe Psoriasis Treatment Market: Segmentation By Type, By Treatment Method (2020-2025)
9.1 Europe Psoriasis Market: Size and Forecast (2020-2025)
Table 45: Europe Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 46: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Table 47: European Union, Health Expenditure, (% of GDP), 2014-2017
Table 48: European Union Population Ages 65 and Above (% of total), 2015-2019
Table 49: European Union Prevalence of Psoriasis, 2014-2017 (In Millions)
Table 50: European Union, Research and Development Expenditure, 2015-2018 (In % of GDP)
9.2 Europe Prominent Companies in Psoriasis Market
Table C: Prominent Psoriasis companies operating in Europe Market
9.3 Market Segmentation By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis- & Erythrodermic Psoriasis)
Table 51: Europe Psoriasis Market- By Type, By Value (USD Million), 2015-2025
9.4 Market Segmentation By Treatment Method (Biologics, Systemic Treatment, Topical Treatment & Others)
Table 52: Europe Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
9.5 Europe Psoriasis Treatment Market: Country Analysis
9.6 Market Opportunity Chart of Europe Psoriasis Market - By Country, By Value (Year-2025)
Table 53: Market Opportunity Chart of Psoriasis Market - By Country, By Value (Year-2025)
9.7 Competitive Scenario of Europe Psoriasis Market: By Country (2019 & 2025)
Table 54: Europe Psoriasis Market- By Country (2019 & 2025)
9.8 Norway Psoriasis Market: Size and Forecast (2020-2025)
Table 55: Norway Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 56: Norway Health Expenditure, (% of GDP), 2014-2017
Table 57: Norway Population Ages 65 and Above (% of total), 2015-2019
Table 58: Norway Prevalence of Psoriasis, 2014-2017 (In Thousands)
Table 59: Norway Research and Development Expenditure, 2015-2018 (In % of GDP)
9.9 Norway Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 60: Norway Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 61: Norway Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
9.10 United Kingdom Psoriasis Market: Size and Forecast (2020-2025)
Table 62: United Kingdom Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 63: United Kingdom Health Expenditure, (% of GDP), 2014-2017
Table 64: United Kingdom Population Ages 65 and Above (% of total), 2015-2019
Table 65: United Kingdom Prevalence of Psoriasis, 2014-2017 (In Millions)
Table 66: United Kingdom Research and Development Expenditure, 2015-2018 (In % of GDP)
9.11 United Kingdom Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 67: United Kingdom Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 68: United Kingdom Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
9.12 Spain Psoriasis Market: Size and Forecast (2020-2025)
Table 69: Spain Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 70: Spain, Health Expenditure, (% of GDP), 2014-2017
Table 71: Spain Population Ages 65 and Above (% of total), 2015-2019
Table 72: Spain Prevalence of Psoriasis, 2014-2017 (In Thousands)
Table 73: Spain Research and Development Expenditure, 2015-2018 (In % of GDP)
9.13 Spain Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 74: Spain Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 75: Spain Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
9.14 Germany Psoriasis Market: Size and Forecast (2020-2025)
Table 76: Germany Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 77: Germany Health Expenditure, (% of GDP), 2014-2017
Table 78: Germany Population Ages 65 and Above (% of total), 2015-2019
Table 79: Germany Prevalence of Psoriasis, 2014-2017 (In Thousands)
Table 80: Germany Research and Development Expenditure, 2015-2018 (In % of GDP)
9.15 Germany Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 81: Germany Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 82: Germany Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
10. Asia Pacific Psoriasis Treatment Market: Segmentation By Type, By Treatment Method (2020-2025)
10.1 Asia Pacific Psoriasis Market: Size and Forecast (2020-2025)
Table 83: Asia Pacific Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 84: Asia Pacific Health Expenditure, (% of GDP), 2014-2017
Table 85: Asia Pacific Population Ages 65 and Above (% of total), 2015-2019
Table 86: Asia Pacific Prevalence of Psoriasis, 2014-2017 (In Thousands)
Table 87: Asia Pacific Research and Development Expenditure, 2015-2018 (In % of GDP)
10.2 Asia Pacific Prominent Companies in Psoriasis Market
Table D: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
Table E: Prominent Psoriasis companies operated in Asia Pacific Market
10.3 Market Segmentation By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis- & Erythrodermic Psoriasis)
Table 88: Asia Pacific Psoriasis Market- By Type, By Value (USD Million), 2015-2025
10.4 Market Segmentation By Treatment (Biologics, Systemic Treatment, Topical Treatment & Others)
Table 89: Asia Pacific Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
10.5 Asia Pacific Psoriasis Market: Country Analysis
10.6 Market Opportunity Chart of Asia Pacific Psoriasis Market - By Country, By Value (Year-2025)
Table 90: Market Opportunity Chart of Asia Pacific Psoriasis Market - By Country, By Value (Year-2025)
10.7 Competitive Scenario of Asia Pacific Psoriasis Market: By Country (2019 & 2025)
Table 91: Asia Pacific Psoriasis Market- By Country (2019 & 2025)
10.8 China Psoriasis Market: Size and Forecast (2020-2025)
Table 92: China Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 93: China Health Expenditure, (% of GDP), 2014-2017
Table 94: China Population Ages 65 and Above (% of total), 2015-2019
Table 95: China Prevalence of Psoriasis, 2014-2017 (In Thousands)
Table 96: China Research and Development Expenditure, 2015-2018 (In % of GDP)
10.9 China Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 97: China Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 98: China Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
10.10 India Psoriasis Market: Size and Forecast (2020-2025)
Table 99: India Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 100: India Health Expenditure, (% of GDP), 2014-2017
Table 101: India Population Ages 65 and Above (% of total), 2015-2019
Table 102: India Prevalence of Psoriasis, 2014-2017 (In Thousands)
Table 103: India Research and Development Expenditure, 2015-2018 (In % of GDP)
10.11 India Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 104: India Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 105: India Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
10.12 South Korea Psoriasis Market: Size and Forecast (2020-2025)
Table 106: South Korea Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 107: South Korea Health Expenditure, (% of GDP), 2014-2017
Table 108: South Korea Population Ages 65 and Above (% of total), 2015-2019
Table 109: South Korea Prevalence of Psoriasis, 2014-2017 (In Thousands)
Table 110: South Korea Research and Development Expenditure, 2015-2018 (In % of GDP)
10.13 South Korea Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 111: South Korea Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 112: South Korea Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
10.14 Japan Psoriasis Market: Size and Forecast (2020-2025)
Table 113: Japan Psoriasis Market Size, By Value, 2015-2025 (USD Million)
Table 114: Japan Health Expenditure, (% of GDP), 2014-2017
Table 115: Japan Population Ages 65 and Above (% of total), 2015-2019
Table 116: Japan Prevalence of Psoriasis, 2014-2017 (In Thousands)
Table 117: Japan Research and Development Expenditure, 2015-2018 (In % of GDP)
10.15 Japan Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
Table 118: Japan Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Table 119: Japan Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
11. Global Psoriasis Treatment Market Dynamics
11.1 Global Psoriasis Market Drivers
11.2 Global Psoriasis Market Restraints
11.3 Global Psoriasis Market Trends
12. Market Attractiveness
12.1.1 Market Attractiveness Chart of Global Psoriasis Market - By Type (Year 2025)
Table 120: Market Attractiveness Chart of Global Psoriasis Market - By Type (Year-2025)
12.1.2 Market Attractiveness Chart of Global Psoriasis Market - By Treatment Method (Year 2025)
Table 121: Market Attractiveness Chart of Global Psoriasis Market - By Treatment Method (Year-2025)
12.1.3 Market Attractiveness Chart of Global Psoriasis Market - By Region, By Value, (Year-2025)
Table 122: Market Attractiveness Chart of Global Psoriasis Market - By Region, By Value, (Year-2025)
13. Competitive Landscape
13.1 Psoriasis Pipeline Analysis
Table F: List of Drugs in Phase I
Table G: List of Drugs in Phase II
Table H: List of Drugs in Phase III
Table I: List of Drugs in FDA- Approved
13.2 Market Share Analysis
Table 123: Market Share of global leaders in Psoriasis, By Company (%) (2019)
14. Company Profiles (Business Description, Financial Analysis, Business Strategy)
14.1 UCB
Table 124: UCB, Revenue, 2015-2019 (USD Millions)
Table 125: UCB, Revenue, By Segment, 2019 (in %)
Table 126: UCB, Profit, 2015- 2019(USD Million)
Table 127: UCB, Revenue, By Region, 2019 (in %)
14.2 Sun Pharmaceutical Industries LTD
Table 128: Sun Pharmaceutical Industries LTD, Revenue, 2015-2019 (USD Millions)
Table 129: Sun Pharmaceutical Industries LTD, Revenue, By Geography Segment, 2019 (in %)
Table 130: Sun Pharmaceutical Industries LTD, Profit, 2015- 2019(USD Million)
14.3 Boehringer Ingelheim
Table 131: Boehringer Ingelheim, Net sales, 2015-2019 (USD Millions)
Table 132: Boehringer Ingelheim, Revenue, By Business Segment, 2019 (in %)
Table 133: Boehringer Ingelheim, Profit, 2015- 2019(USD Million)
Table 134: Boehringer Ingelheim, Revenue, By Geography Segment, 2019 (in %)
14.4 Almirall
Table 135: Almirall, Net sales, 2015-2019 (USD Millions)
Table 136: Almirall, Revenue, By Geography Segment, 2019 (in %)
Table 137: Almirall, Net Income/Loss, 2015- 2019(USD Million)
14.5 Bausch Health
Table 138: Bausch Health, Revenue, 2015-2019 (USD Millions)
Table 139: Bausch Health, Revenue, By Segment, 2019 (in %)
Table 140: Bausch Health, Net Income/ Loss, 2015- 2019(USD Million)
Table 141: Bausch Health, Revenue, By Region, 2019 (in %)
Table 142: Bausch Health, Revenue, By Type, 2019 (in %)
14.6 Abbvie Inc
Table 143: Abbvie Inc , Net sales, 2015-2019 (USD Millions)
Table 144: Abbvie Inc , Revenue, By Pharmaceuticals Product, 2019 (in %)
Table 145: Abbvie Inc, Net Earnings, 2015- 2019(USD Million)
Table 146: Abbvie Inc , Revenue, By Geography Segment, 2019 (in %)
14.7 Eli Lilly and Company
Table 147: Eli Lilly and Company, Net sales, 2015-2019 (USD Millions)
Table 148: Eli Lilly and Company, Revenue, By Pharmaceuticals Product, 2019 (in %)
Table 149: Eli Lilly and Company, Net Earnings, 2015- 2019(USD Million)
Table 150: Eli Lilly and Company, Revenue, By Geography, 2019 (in %)
14.8 Pfizer Inc.
Table 151: Pfizer Inc., Revenue, 2015-2019 (USD Millions)
Table 152: Pfizer Inc., Revenue, By Geography Segment, 2019 (in %)
Table 153: Pfizer Inc., Profit, 2015- 2019(USD Million)
14.9 Amgen Inc
Table 154: Amgen Inc., Revenue, 2015-2019 (USD Millions)
Table 155: Amgen Inc., Revenue, By Segment, 2019 (in %)
Table 156: Amgen Inc., Net Income/ Loss, 2015- 2019(USD Million)
Table 157: Amgen Inc., Revenue, By Geography, 2019 (in %)
14.10 Johnson & Johnson
Table 158: Johnson & Johnson, Net Sales, 2014 - 2019 (In USD Million)
Table 159: Johnson & Johnson, Net Profit, 2014 - 2019 (In USD Million)
Table 160: Johnson & Johnson, Net Sales, By Geographic Region, 2019 (In %)
Table 161: Johnson & Johnson, Sales Revenue, By Business Segment, 2019 (In %)
Table 162: Johnson & Johnson, Net Sales, By Consumer Business Segment, 2019 (In %)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook